These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8127929

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M, Kummer J, Agnoli A, Gentili P, Lorizio A, Anand R.
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [Abstract] [Full Text] [Related]

  • 3. Multicenter double-blind study of moclobemide and maprotiline.
    Vaz-Serra A, Figueira ML, Firmino H, Albuquerque AJ, Jara JM, Pestana LC.
    Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of moclobemide and tranylcypromine in depression.
    Heinze G, Rossel L, Gabelic I, Galeano-Munoz J, Stabl M, Allen SR.
    Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
    Baumhackl U, Bizière K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E, Stabl M.
    Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R).
    Newburn G, Edwards R, Thomas H, Collier J, Fox K, Collins C, Cramer D, Reeves J, Caracatsanis A.
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R, Márquez CA, Traballi CA, Portes N.
    Acta Psychiatr Scand Suppl; 1990 Aug; 360():54-6. PubMed ID: 2123367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M, Cattiez P, Franck G, Burton P, Defleur J, Hermans W, Roelandts A, Wolfrum C, Berger M, Hellstern K.
    Acta Psychiatr Scand Suppl; 1990 Aug; 360():50-1. PubMed ID: 2248071
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L, Moll E.
    Acta Psychiatr Scand Suppl; 1990 Aug; 360():61-2. PubMed ID: 2248075
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.